News for hackers. Stuff that matters.

A comment on Biohackers take aim at big pharma’s stranglehold on insulin. Parent comment

Re:Biohackers take aim at big pharma’s stranglehold on insulin by dragonwriter on Tuesday June 29, 2021 @01:00AM (#27671971)
> I mean in many cases the product is still profitable for them at the reduced rate, but why settle?

Because for a customer who would pay nothing if their only choice was to get the drug at full price, settling for a reduced price (especially when you also get a tax deduction, and some PR benefit from advertising the discount for the needy) is more profitable than not settling.

[ Parent | on HN ]
Re:Biohackers take aim at big pharma’s stranglehold on insulin by emodendroket on Tuesday June 29, 2021 @08:18AM (#27674773)
You're not really getting what I'm saying. That's what the program allows them to do, while still charging an exorbitant rate to others.
[ Parent | on HN ]